Jackson Square Partners LLC raised its stake in athenahealth, Inc. (NASDAQ:ATHN) by 55.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 525,738 shares of the health services provider’s stock after acquiring an additional 187,491 shares during the period. Jackson Square Partners LLC owned about 1.31% of athenahealth worth $65,380,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its holdings in shares of athenahealth by 37.3% during the first quarter. Dimensional Fund Advisors LP now owns 121,650 shares of the health services provider’s stock worth $13,708,000 after purchasing an additional 33,061 shares during the last quarter. Aperio Group LLC grew its holdings in shares of athenahealth by 10.6% during the second quarter. Aperio Group LLC now owns 6,709 shares of the health services provider’s stock worth $943,000 after purchasing an additional 641 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of athenahealth by 13.7% during the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares during the last quarter. World Asset Management Inc bought a new stake in shares of athenahealth during the second quarter worth $253,000. Finally, Seven Bridges Advisors LLC grew its holdings in shares of athenahealth by 5.4% during the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after purchasing an additional 67 shares during the last quarter.

In other athenahealth news, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $130.38, for a total value of $39,114.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Bradford Kyle Armbrester sold 1,000 shares of the stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $128.56, for a total value of $128,560.00. The disclosure for this sale can be found here. Insiders have sold 9,283 shares of company stock worth $1,175,908 in the last ninety days. 3.20% of the stock is currently owned by insiders.

athenahealth, Inc. (ATHN) opened at $133.78 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67. athenahealth, Inc. has a one year low of $90.11 and a one year high of $158.66. The stock has a market capitalization of $5,356.37, a price-to-earnings ratio of 113.43, a PEG ratio of 5.02 and a beta of 1.57.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The business had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. During the same quarter in the prior year, the firm posted $0.60 earnings per share. The firm’s revenue for the quarter was up 10.1% compared to the same quarter last year. analysts forecast that athenahealth, Inc. will post 1.2 EPS for the current fiscal year.

Several analysts have recently commented on ATHN shares. Robert W. Baird restated a “buy” rating and set a $170.00 target price on shares of athenahealth in a report on Thursday, August 31st. Jefferies Group decreased their target price on athenahealth from $135.00 to $120.00 and set a “hold” rating on the stock in a report on Friday, September 15th. KeyCorp restated a “buy” rating and set a $170.00 target price on shares of athenahealth in a report on Sunday, September 17th. Royal Bank Of Canada started coverage on athenahealth in a report on Tuesday, September 19th. They set a “sector perform” rating and a $153.00 target price on the stock. Finally, TheStreet cut athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $143.22.

TRADEMARK VIOLATION WARNING: This report was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/12/07/jackson-square-partners-llc-has-65-38-million-holdings-in-athenahealth-inc-athn.html.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.